New drug trial offers hope before chemotherapy for Tough-to-Treat breast cancer

NCT ID NCT07205822

Summary

This study is testing an investigational drug called Dato-DXd for people with a specific type of advanced breast cancer that has spread and no longer responds to standard hormone treatments. The goal is to see if this drug, given as an IV infusion every 3 weeks, can effectively control the cancer and delay its progression before patients need to start chemotherapy. Researchers will closely monitor how well the treatment works and its safety in about 100 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    WITHDRAWN

    Largo, Florida, 33770, United States

  • Research Site

    RECRUITING

    Fort Wayne, Indiana, 46825, United States

  • Research Site

    RECRUITING

    Omaha, Nebraska, 68130, United States

  • Research Site

    NOT_YET_RECRUITING

    New York, New York, 10021, United States

  • Research Site

    RECRUITING

    Houston, Texas, 77024, United States

  • Research Site

    RECRUITING

    Puyallup, Washington, 98373, United States

  • Research Site

    RECRUITING

    Beijing, 100021, China

  • Research Site

    NOT_YET_RECRUITING

    Changsha, 410013, China

  • Research Site

    RECRUITING

    Guangzhou, 510060, China

  • Research Site

    NOT_YET_RECRUITING

    Linyi, 276001, China

  • Research Site

    NOT_YET_RECRUITING

    Shandong, 250117, China

  • Research Site

    NOT_YET_RECRUITING

    Wuhan, 430071, China

  • Research Site

    NOT_YET_RECRUITING

    Zhengzhou, 450008, China

  • Research Site

    RECRUITING

    Clermont-Ferrand, 63050, France

  • Research Site

    RECRUITING

    La Roche-sur-Yon, 85925, France

  • Research Site

    RECRUITING

    Montpellier, 34070, France

  • Research Site

    NOT_YET_RECRUITING

    Paris, 75005, France

  • Research Site

    RECRUITING

    Pierre-Bénite, 69310, France

  • Research Site

    RECRUITING

    Aviano, 33081, Italy

  • Research Site

    RECRUITING

    Florence, 50134, Italy

  • Research Site

    RECRUITING

    Meldola, 47014, Italy

  • Research Site

    NOT_YET_RECRUITING

    Milan, 20141, Italy

  • Research Site

    RECRUITING

    Naples, 80131, Italy

  • Research Site

    NOT_YET_RECRUITING

    Roma, 00168, Italy

  • Research Site

    RECRUITING

    Bukgu, 41404, South Korea

  • Research Site

    NOT_YET_RECRUITING

    Goyang-si, 410-769, South Korea

  • Research Site

    RECRUITING

    Seoul, 03080, South Korea

  • Research Site

    RECRUITING

    Seoul, 06273, South Korea

  • Research Site

    RECRUITING

    Seoul, 06351, South Korea

  • Research Site

    RECRUITING

    Seoul, 06591, South Korea

  • Research Site

    RECRUITING

    Seoul, 136705, South Korea

  • Research Site

    RECRUITING

    Seoul, 3722, South Korea

  • Research Site

    RECRUITING

    Seoul, 5505, South Korea

  • Research Site

    NOT_YET_RECRUITING

    A Coruña, 15006, Spain

  • Research Site

    RECRUITING

    Barcelona, 08035, Spain

  • Research Site

    NOT_YET_RECRUITING

    Granada, 18007, Spain

  • Research Site

    NOT_YET_RECRUITING

    Madrid, 28033, Spain

  • Research Site

    NOT_YET_RECRUITING

    Madrid, 28040, Spain

  • Research Site

    NOT_YET_RECRUITING

    Seville, 41009, Spain

  • Research Site

    NOT_YET_RECRUITING

    Valencia, 46009, Spain

Conditions

Explore the condition pages connected to this study.